Compare · IQMD vs SONO
IQMD vs SONO
Side-by-side comparison of Intelligent Medicine Acquisition Corp. (IQMD) and Sonos Inc. (SONO): market cap, price performance, sector, and recent activity on the wire.
Summary
- IQMD operates in Industrials, while SONO operates in Consumer Staples - the two are in different parts of the market.
- SONO is the larger of the two at $1.78B, about 6.4x IQMD ($280.1M).
- SONO has hit the wire 1 time in the past 4 weeks while IQMD has been quiet.
- SONO has more recent analyst coverage (12 ratings vs 0 for IQMD).
- Company
- Intelligent Medicine Acquisition Corp.
- Sonos Inc.
- Price
- $11.05+7.28%
- $14.74+2.25%
- Market cap
- $280.1M
- $1.78B
- 1M return
- -
- +11.08%
- 1Y return
- -
- +60.74%
- Industry
- Consumer Electronics/Appliances
- Consumer Electronics/Appliances
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2018
- News (4w)
- 0
- 1
- Recent ratings
- 0
- 12
Intelligent Medicine Acquisition Corp.
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science. The company was incorporated in 2021 and is based in Bethesda, Maryland.
Sonos Inc.
Sonos, Inc., together with its subsidiaries, designs, develops, manufactures, and sells multi-room audio products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides wireless speakers, home theater speakers, components, and accessories. It offers its products through approximately 10,000 third-party retail stores, including custom installers of home audio systems; and e-commerce retailers, as well as through its Website sonos.com. The company was formerly known as Rincon Audio, Inc. and changed its name to Sonos, Inc. in May 2004. Sonos, Inc. was founded in 2002 and is headquartered in Santa Barbara, California.
Latest IQMD
- SEC Form SC 13G filed by Intelligent Medicine Acquisition Corp.
- SEC Form 15-12G filed by Intelligent Medicine Acquisition Corp.
- SEC Form 25-NSE filed by Intelligent Medicine Acquisition Corp.
- SEC Form 3: New insider Goldman Sachs Group Inc claimed ownership of 200,000 shares
- Intelligent Medicine Acquisition Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Intelligent Medicine Acquisition Corp. Announces It Will Redeem Its Public Shares
- Intelligent Medicine Acquisition Corp. Announces It Will Redeem Its Public Shares
- SEC Form 10-K filed by Intelligent Medicine Acquisition Corp.
- SEC Form SC 13G/A filed by Intelligent Medicine Acquisition Corp. (Amendment)
- Intelligent Medicine Acquisition Corp. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
Latest SONO
- Sonos Announces Date for Second Quarter Fiscal 2026 Financial Results and Conference Call
- Amendment: SEC Form SCHEDULE 13G/A filed by Sonos Inc.
- Large owner Coliseum Capital Management, Llc bought $3,068,690 worth of shares (228,920 units at $13.41) (SEC Form 4)
- Large owner Coliseum Capital Management, Llc bought $12,959,400 worth of shares (920,000 units at $14.09) (SEC Form 4)
- Director Genachowski Julius gifted 15,427 shares and received a gift of 15,427 shares, decreasing direct ownership by 22% to 53,775 units (SEC Form 4)
- Sonos Returns to the System That Built the Brand with Two Essential Speakers That Deliver Effortless Sound Throughout the Home
- Director Mildenhall Jonathan was granted 12,725 shares, increasing direct ownership by 46% to 40,272 units (SEC Form 4)
- Director Kennedy Joseph Jude was granted 12,725 shares, increasing direct ownership by 776% to 14,364 units (SEC Form 4)
- Director Genachowski Julius was granted 17,497 shares, increasing direct ownership by 34% to 69,202 units (SEC Form 4)
- Director Fields Mandy J was granted 12,725 shares, increasing direct ownership by 776% to 14,364 units (SEC Form 4)